Operating
Stock-Based Comp
Guardant Health Stock-Based Comp increased by 10.2% to $47.61M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 26.1%, from $37.76M to $47.61M. Over 4 years (FY 2021 to FY 2025), Stock-Based Comp shows relatively stable performance with a 2.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryProfitability
SignalLower is better
VolatilityModerate
First reportedQ1 2016
Last reportedQ1 2026May 7, 2026
How to read this metric
High levels may indicate aggressive talent acquisition but also lead to significant shareholder dilution.
Detailed definition
This represents the non-cash expense recognized for equity-based awards granted to employees and directors. It is added...
Peer comparison
High in technology and biotech sectors; a key metric for evaluating true operating costs.
Metric ID:
stock_based_compensationHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $34.51M | $35.02M | $26.86M | $24.8M | $25.54M | $20.64M | $23.7M | $22.27M | $22.35M | $21.82M | $24.32M | $27.04M | $27.24M | $49.77M | $36.37M | $37.76M | $42.46M | $42.81M | $43.19M | $47.61M |
| QoQ Change | — | +1.5% | -23.3% | -7.7% | +3.0% | -19.2% | +14.8% | -6.1% | +0.4% | -2.4% | +11.5% | +11.2% | +0.7% | +82.7% | -26.9% | +3.8% | +12.5% | +0.8% | +0.9% | +10.2% |
| YoY Change | — | — | — | — | -26.0% | -41.1% | -11.7% | -10.2% | -12.5% | +5.7% | +2.6% | +21.4% | +21.8% | +128.1% | +49.5% | +39.6% | +55.9% | -14.0% | +18.8% | +26.1% |
Range$20.64M – $49.77M
CAGR+7.0%
Avg YoY Growth+15.9%
Median YoY Growth+12.2%
Current Streak5 quarters growth
Stock-Based Comp at Other Companies
Frequently Asked Questions
- What is Guardant Health's stock-based comp?
- Guardant Health (GH) reported stock-based comp of $47.61M in Q1 2026.
- How has Guardant Health's stock-based comp changed year-over-year?
- Guardant Health's stock-based comp increased by 26.1% year-over-year, from $37.76M to $47.61M.
- What is the long-term trend for Guardant Health's stock-based comp?
- Over 4 years (2021 to 2025), Guardant Health's stock-based comp has grown at a 2.4% compound annual growth rate (CAGR), from $151.45M to $166.22M.
- What does stock-based comp mean?
- The cost of employee compensation paid in company stock rather than cash.